AbbVie Inc.: cash_and_equivalents
| Value | {"amount": 6088000000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2017-06-30) |
| Status | current |
| Entity | AbbVie Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:44:34.547090+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/97c36173-0628-4cc6-8155-bfe3dd16c877
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001551152-17-000025Retrieved: 2026-08-19T15:44:34.547090+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001551152/cash-and-equivalents/2017-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/97c36173-0628-4cc6-8155-bfe3dd16c877
History
- no predecessors — first report